First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 161.82 USD -3.27%
Updated: Apr 26, 2024

Abbvie Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abbvie Inc
Additional Paid In Capital Peer Comparison

Comparables:
GILD
AMGN
MRNA
VRTX
REGN

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Additional Paid In Capital
$20.2B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Additional Paid In Capital
$6.5B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
2%
Amgen Inc
NASDAQ:AMGN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Moderna Inc
NASDAQ:MRNA
Additional Paid In Capital
$371m
CAGR 3-Years
-57%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Additional Paid In Capital
$7.4B
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
3%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Additional Paid In Capital
$11.4B
CAGR 3-Years
19%
CAGR 5-Years
24%
CAGR 10-Years
19%

See Also

What is Abbvie Inc's Additional Paid In Capital?
Additional Paid In Capital
20.2B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Additional Paid In Capital amounts to 20.2B USD.

What is Abbvie Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
19%

Over the last year, the Additional Paid In Capital growth was 5%. The average annual Additional Paid In Capital growth rates for Abbvie Inc have been 5% over the past three years , 6% over the past five years , and 19% over the past ten years .